IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody

Antidote Therapeutics, Inc., Sykesville MD

Investigators

Linked publications, trials & patents

Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text.